摘要 |
PCT No. PCT/EP96/00677 Sec. 371 Date Aug. 12, 1997 Sec. 102(e) Date Aug. 12, 1997 PCT Filed Feb. 14, 1996 PCT Pub. No. WO96/25931 PCT Pub. Date Aug. 29, 1996The present invention is concerned with the method of using a 2,3-dihydro-imidazo[2,1-b]benzothiazole derivative for the manufacture of a medicament for the therapeutic or prophylactic treatment of humans suffering from ageing of, or degenerative diseases of the nervous and vascular system which are associated with oxidative stress. |
申请人 |
JANSSEN PHARMACEUTICA N.V.;DE BRABANDER, MARC, JORIS;LESAGE, ANNE, SIMONE, JOSEPHINE;LEYSEN, JOSEPHA, EDUARDA, MARIA, FRANCISCA |
发明人 |
DE BRABANDER, MARC, JORIS;LESAGE, ANNE, SIMONE, JOSEPHINE;LEYSEN, JOSEPHA, EDUARDA, MARIA, FRANCISCA |